J. Naidoo

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

S. Digumarthy, J. Roth, M. Mino‐Kenudson, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Discovery of selective non-small cell lung cancer toxins that target mitochondrial Complex I

Prashant Mishra, Nikhil Madhusudhan, D. Nijhawan, 2020 .

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.

J. Wolchok, M. Lacouture, M. Postow, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.

J. Wolchok, M. Lacouture, M. Postow, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Immune modulation for cancer therapy

J. Wolchok, J. Naidoo, D. Page, 2014, British Journal of Cancer.

Small-molecule activation of the TRAIL receptor DR5 in human cancer cells.

Xiaodong Wang, She Chen, Xiaoguang Lei, 2013, Nature chemical biology.